| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.67 | 0.001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.68 | 0.002 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |